Morgan Stanley analyst, David Risinger, reiterated his Equalweight rating on shares of Mylan (NASDAQ: MYL) and cut his price target ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE